Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

Combination Therapy ◽

Depressive Disorder ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.13180 ◽

2020 ◽

Author(s):

Saba Hoobehfekr ◽

Hossein Sanjari Moghaddam ◽

Mohammadreza Shalbafan ◽

Maryam Ghazizadeh Hashemi ◽

Mohammad Mehdi Pirmoradi ◽

...

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial

Journal of Affective Disorders ◽

10.1016/j.jad.2020.01.065 ◽

2020 ◽

Vol 265 ◽

pp. 99-103

Author(s):

Lili Gao ◽

Chenghan Wu ◽

Yuansheng Liao ◽

Jinmin Wang

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry ◽

10.1016/j.pnpbp.2011.01.016 ◽

2011 ◽

Vol 35 (4) ◽

pp. 970-973 ◽

Cited By ~ 12

Author(s):

Arash Mowla ◽

Ehsan Kardeh

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

S102. Pilot Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Major Depressive Disorder

Biological Psychiatry ◽

10.1016/j.biopsych.2018.02.993 ◽

2018 ◽

Vol 83 (9) ◽

pp. S386-S387 ◽

Cited By ~ 2

Author(s):

Morgan Alexander ◽

Sankaraleengam Alagapan ◽

Courtney Lugo ◽

Juliann Mellin ◽

Caroline Lustenberger ◽

...

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Alternating Current ◽

Transcranial Alternating Current Stimulation

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL

Depression and Anxiety ◽

10.1002/da.22195 ◽

2013 ◽

Vol 30 (11) ◽

pp. 1084-1088 ◽

Cited By ~ 37

Author(s):

Ahmad Ghanizadeh ◽

Arvin Hedayati

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Effect of prebiotic and probiotic supplementation on circulating pro-inflammatory cytokines and urinary cortisol levels in patients with major depressive disorder: A double-blind, placebo-controlled randomized clinical trial

Journal of Functional Foods ◽

10.1016/j.jff.2018.11.041 ◽

2019 ◽

Vol 52 ◽

pp. 596-602 ◽

Cited By ~ 9

Author(s):

Asma Kazemi ◽

Ahmad Ali Noorbala ◽

Kamal Azam ◽

Kurosh Djafarian

Keyword(s):

Clinical Trial ◽

Depressive Disorder ◽

Inflammatory Cytokines ◽

Urinary Cortisol ◽

Major Depressive ◽

Probiotic Supplementation ◽

Double Blind ◽

Double Blind Placebo ◽

Pro Inflammatory Cytokines

Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2017.1397700 ◽

2017 ◽

Vol 23 (4) ◽

pp. 245-250 ◽

Cited By ~ 2

Author(s):

Jing Wang ◽

Xi-Fang Liu ◽

Chong Feng ◽

Quan Bao ◽

Hong-Ran Fu

Keyword(s):

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Cited By ~ 233

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Depressive Disorder ◽

Elderly Patients ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79213-2 ◽

2009 ◽

Vol 2009 ◽

pp. 281-282

Author(s):

J.C. Ballenger

Keyword(s):

Depressive Disorder ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial